Albizia Procera

Albizia procera  Benth.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Mimosaceae.
Habitat All over India.
Ayurvedic Shveta Shirisha (bark— white or greenish-white).
Action Bark—a decoction is given in rheumatism and haemorrhage.
Taxonomic Cohort Genus Albizia (3 documented species); Family Mimosaceae (24 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Albizia procera (taxonomically cited with authority Benth.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Mimosaceae (primary family classification: Mimosaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: All over India.

Across classical and vernacular Indian systems of medicine, Albizia procera is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Shveta Shirisha (bark— white or greenish-white). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Albizia procera are: Bark—a decoction is given in rheumatism and haemorrhage. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Albizia procera establish the following evidence base: The bark contains beta-sitosterol and yields 12–17% tannins. An oleanolic acid saponin, proceric acid saponin mixture from seeds and root saponin exhibit spermicidal activity.

image2

Botanical Reference 1: Albizia procera — Botanical specimen

image3

Botanical Reference 2: Albizia procera — Botanical specimen

image4

Botanical Reference 3: Albizia procera — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Albizia comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Albizia amara (Action: Leaf and flower—antiinflammatory, used for boils and ulcers. Leaf—used for…); Albizia lebbeck (Action: Antiseptic, antibacterial, antiallergic, antidermatosis, antidysenteric….). Comparing Albizia procera alongside its congeners in genus Albizia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Mimosaceae encompasses 24 documented medicinal species (1.32% of the 1,814-species flora). Other representative medicinal members of Mimosaceae include: Acacia arabica indica (Babbuula), Acacia canescens (Aadaari), Acacia catechu (Khadira), Acacia chundra (Khadira), Dichrostachys cinerea (Virataru). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 24 medicinal species of family Mimosaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Albizia procera follow the plant-part modalities specified under its therapeutic action (Bark—a decoction is given in rheumatism and haemorrhage), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Albizia procera integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top